CLINICAL_TRIALS
trial_result
· 2022-04-27
Clinical Trial Update: Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease [Phase 2]
Summary
Phase 2 trial investigating pirfenidone to prevent progression of chronic kidney disease. The study status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Veterans Medical Research Foundation | Conditions: Chronic Kidney Disease | Phase 2 | Status: UNKNOWN